FRA:QIA - NL0015002CX3 - Common Stock
Taking everything into account, QIA scores 6 out of 10 in our fundamental rating. QIA was compared to 17 industry peers in the Life Sciences Tools & Services industry. Both the health and profitability get an excellent rating, making QIA a very profitable company, without any liquidiy or solvency issues. QIA has a decent growth rate and is not valued too expensively. This makes QIA very considerable for quality investing!
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 6.41% | ||
ROE | 10.65% | ||
ROIC | 8.51% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 26.4% | ||
PM (TTM) | 18.3% | ||
GM | 63.73% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.25 | ||
Debt/FCF | 2.91 | ||
Altman-Z | 4.18 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.61 | ||
Quick Ratio | 1.35 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 21.06 | ||
Fwd PE | 19.04 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 21.62 | ||
EV/EBITDA | 15.12 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 0.51% |
FRA:QIA (8/22/2025, 7:00:00 PM)
42.55
-0.03 (-0.07%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 0.51% |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 21.06 | ||
Fwd PE | 19.04 | ||
P/S | 5.26 | ||
P/FCF | 21.62 | ||
P/OCF | 15.89 | ||
P/B | 3.06 | ||
P/tB | 16.78 | ||
EV/EBITDA | 15.12 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 6.41% | ||
ROE | 10.65% | ||
ROCE | 11.47% | ||
ROIC | 8.51% | ||
ROICexc | 10.68% | ||
ROICexgc | 45.66% | ||
OM | 26.4% | ||
PM (TTM) | 18.3% | ||
GM | 63.73% | ||
FCFM | 24.31% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.25 | ||
Debt/FCF | 2.91 | ||
Debt/EBITDA | 1.22 | ||
Cap/Depr | 94.78% | ||
Cap/Sales | 8.78% | ||
Interest Coverage | 250 | ||
Cash Conversion | 92.78% | ||
Profit Quality | 132.83% | ||
Current Ratio | 1.61 | ||
Quick Ratio | 1.35 | ||
Altman-Z | 4.18 |